PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in Norway
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.335
https://www.valueinhealthjournal.com/article/S1098-3015(11)01897-3/fulltext
Section Title :
Mental Health
Section Order :
310
First Page :
A292
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01897-3&doi=10.1016/j.jval.2011.08.335